Globhy
AllBusinessHealthMarketingTechnologyTravelUncategorized
Posted on 10 minutes agoEdited on 10 minutes ago

Share:

NGS Sample Preparation Market Size to Rise from USD 3.08 Billion in 2026 to USD 8.52 Billion by 2034

NGS Sample Preparation Market Size to Rise from USD 3.08 Billion in 2026 to USD 8.52 Billion by 2034

According to StraitsResearch, the global NGS sample preparation market size was valued at USD 2.71 billion in 2025 and is projected to grow from USD 3.08 billion in 2026 to USD 8.52 billion by 2034, registering a CAGR of 13.58% during the forecast period from 2026 to 2034.

NGS Sample Preparation Market Size, Share to 2034

Next-generation sequencing (NGS) sample preparation involves the processes and technologies used to extract, purify, quantify, and prepare DNA or RNA samples before sequencing. These workflows are essential for genomic research, disease diagnostics, drug discovery, and precision medicine. Advances in sequencing technologies, expanding clinical applications, and the need for reliable genomic data are encouraging laboratories to adopt efficient and automated sample preparation solutions.

According to StraitsResearch, the global NGS sample preparation market size was valued at USD 2.71 billion in 2025 and is projected to grow from USD 3.08 billion in 2026 to USD 8.52 billion by 2034, registering a CAGR of 13.58% during the forecast period from 2026 to 2034. North America dominated the NGS sample preparation market with a share of 41.5% in 2025.

NGS Sample Preparation Market

The Next-Generation Sequencing (NGS) sample preparation market encompasses products, technologies, and services used to prepare biological samples for high-throughput DNA and RNA sequencing. The process involves sample extraction, purification, fragmentation, library preparation, target enrichment, and quality control to ensure accurate sequencing results. Sample preparation plays a critical role in determining sequencing efficiency, data quality, and experimental reproducibility across research and clinical applications. Key products include library preparation kits, reagents, consumables, extraction systems, and automated sample preparation instruments.

The market is experiencing significant growth due to the expanding application of genomic research, personalized medicine, and molecular diagnostics. Pharmaceutical and biotechnology companies increasingly use NGS technologies for drug discovery, biomarker identification, cancer research, and clinical trial development. The growing adoption of precision medicine also supports demand for reliable sample preparation solutions, as genomic information helps healthcare professionals identify disease-associated genetic variations and select targeted treatment approaches.

Technological advancements in library preparation are further transforming the market. Automation, miniaturization, and integrated workflows reduce manual intervention, processing time, and sample contamination risks. These developments improve laboratory productivity and make sequencing workflows more accessible to research institutions, diagnostic laboratories, and healthcare facilities. In addition, the development of targeted sequencing panels and specialized preparation kits supports applications involving low-input samples, degraded DNA, and circulating tumor DNA.

Research investments in genomics, genetic disease diagnosis, and oncology are creating further opportunities for market participants. Government-funded genome sequencing initiatives and collaborations between academic institutions, biotechnology companies, and healthcare organizations are strengthening demand for advanced sequencing infrastructure. North America represents an important market due to its established biotechnology sector, research capabilities, and adoption of genomic technologies, while Asia-Pacific offers growth opportunities through expanding healthcare infrastructure and investments in life sciences.

The competitive landscape includes established life science companies and specialized genomics technology providers. Major participants include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., QIAGEN N.V., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., and Twist Bioscience Corporation. Their strategies focus on product innovation, strategic collaborations, automation capabilities, and expanded sequencing applications. Overall, the growing importance of genomic analysis in healthcare and life sciences is expected to strengthen demand for efficient, accurate, and scalable NGS sample preparation solutions.

Market Drivers

Increasing Use of Genomic Testing in Disease Diagnosis

NGS technologies are increasingly used to identify genetic variations associated with cancer, inherited disorders, and other complex diseases. Accurate sample preparation is essential for generating reliable sequencing results. The expanding use of genomic testing in clinical diagnostics is therefore supporting demand for specialized kits, reagents, and laboratory instruments.

Expansion of Precision Medicine and Drug Discovery

Pharmaceutical and biotechnology companies use genomic information to understand disease mechanisms, identify therapeutic targets, and evaluate treatment responses. NGS sample preparation solutions help researchers process biological samples for these applications, supporting demand across drug discovery and personalized medicine programs.

Automation of Sequencing Preparation Workflows

Laboratories are adopting automated library preparation, nucleic acid extraction, and quality-control systems to improve workflow consistency and processing capacity. Automation can reduce manual handling, improve reproducibility, and support higher sample throughput, encouraging investment in advanced preparation technologies.

Market Challenges

High Costs of Sequencing Workflows

NGS sample preparation requires specialized instruments, reagents, consumables, and trained personnel. The overall cost of sequencing workflows can be substantial, creating adoption barriers for smaller laboratories and research institutions with limited budgets.

Complexity of Sample Preparation Protocols

Different sample types and sequencing applications require specific extraction, purification, library preparation, and quality-control procedures. Protocol complexity can affect sample quality and workflow reproducibility, particularly in laboratories handling diverse biological materials.

Data Quality and Sample Contamination Risks

Contamination, low sample quality, and inconsistencies during preparation can affect sequencing accuracy and lead to unreliable results. Laboratories must maintain strict quality-control procedures, which increase operational requirements and the need for skilled technical personnel.

Market Segmentation

Share:

More in Business

View category
Tunnel Boring Machine Market Research Report: Growth Drivers, Trends and Industry Outlook
Business
1

Tunnel Boring Machine Market Research Report: Growth Drivers, Trends and Industry Outlook

Tunnel boring machines (TBMs) excavate tunnels through various rock and soil formations and are used in mining, railway, highway, water supply, wastewater, oil and gas pipeline, and hydropower projects. Their ability to reduce construction time compared with conventional methods supports wider adoption. Increased investment in road, railway, and other infrastructure projects is expected to further drive demand for tunnel boring machines.

READ ARTICLE